1. Home
  2. FDUS vs AVDL Comparison

FDUS vs AVDL Comparison

Compare FDUS & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FDUS
  • AVDL
  • Stock Information
  • Founded
  • FDUS 2011
  • AVDL 2015
  • Country
  • FDUS United States
  • AVDL Ireland
  • Employees
  • FDUS N/A
  • AVDL N/A
  • Industry
  • FDUS Finance/Investors Services
  • AVDL Biotechnology: Pharmaceutical Preparations
  • Sector
  • FDUS Finance
  • AVDL Health Care
  • Exchange
  • FDUS Nasdaq
  • AVDL Nasdaq
  • Market Cap
  • FDUS 759.3M
  • AVDL 784.6M
  • IPO Year
  • FDUS 2011
  • AVDL 1996
  • Fundamental
  • Price
  • FDUS $20.39
  • AVDL $7.83
  • Analyst Decision
  • FDUS
  • AVDL Strong Buy
  • Analyst Count
  • FDUS 0
  • AVDL 7
  • Target Price
  • FDUS N/A
  • AVDL $18.86
  • AVG Volume (30 Days)
  • FDUS 318.4K
  • AVDL 815.5K
  • Earning Date
  • FDUS 03-06-2025
  • AVDL 03-03-2025
  • Dividend Yield
  • FDUS 11.33%
  • AVDL N/A
  • EPS Growth
  • FDUS N/A
  • AVDL N/A
  • EPS
  • FDUS 2.40
  • AVDL N/A
  • Revenue
  • FDUS $146,154,000.00
  • AVDL $169,117,000.00
  • Revenue This Year
  • FDUS $1.34
  • AVDL $50.78
  • Revenue Next Year
  • FDUS $2.10
  • AVDL $32.44
  • P/E Ratio
  • FDUS $8.49
  • AVDL N/A
  • Revenue Growth
  • FDUS 12.33
  • AVDL 504.79
  • 52 Week Low
  • FDUS $18.41
  • AVDL $7.39
  • 52 Week High
  • FDUS $23.55
  • AVDL $19.09
  • Technical
  • Relative Strength Index (RSI)
  • FDUS 31.46
  • AVDL 40.37
  • Support Level
  • FDUS $20.89
  • AVDL $7.98
  • Resistance Level
  • FDUS $21.00
  • AVDL $8.31
  • Average True Range (ATR)
  • FDUS 0.31
  • AVDL 0.34
  • MACD
  • FDUS -0.05
  • AVDL -0.04
  • Stochastic Oscillator
  • FDUS 12.42
  • AVDL 5.98

About FDUS Fidus Investment Corporation

Fidus Investment Corp is an externally managed, closed-end, non-diversified management investment company that has elected to be treated as a business development company. The company provides customized debt and equity financing solutions to lower middle-market companies. Its investment objective is to provide attractive risk-adjusted returns by generating both current income from debt investments and capital appreciation from equity related investments. The company's portfolio of investments is comprised of securities of companies from different industries such as, Information Technology Services, Business Services, Healthcare Products among others.

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

Share on Social Networks: